AXREM is delighted to announce the appointment of Bob Childe, Chief Commercial Officer at Soliton IT Ltd, as the new Vice Chair of the association. Bob will support current Chairman Huw Shurmer in leading AXREM’s strategic direction and member engagement across the UK’s imaging and oncology technology sector.
With over 35 years of experience in healthcare technology, Bob has worked across three AXREM member companies and brings a wealth of insight, leadership, and sector-wide collaboration. His appointment marks a significant milestone for AXREM, not only in recognising his longstanding contributions, but also in reflecting the association’s transformation over the past six years. AXREM now proudly represents over 100 member companies and Bob becomes the first Vice Chair from an SME, demonstrating our commitment to inclusivity and representation across the entire imaging and oncology community.
Bob has played a pivotal role in AXREM’s development, serving as Chair of the Imaging IT Special Focus Group and more recently also as Convener of the Cyber Security Group. His work has championed interoperability, digital resilience, and patient-centric innovation, values that align closely with AXREM’s mission.
Commenting on his appointment, Bob said: “I am honoured to take on the role of Vice Chair and support the continued momentum of AXREM’s work. My career has been defined by a commitment to collaboration, innovation, and raising standards across our industry. I look forward to strengthening AXREM’s voice as a trusted partner to the NHS and government, and ensuring all members, large and small are actively engaged and represented.”
Chairman Huw Shurmer added: “Bob’s appointment reflects AXREM’s evolution into a truly inclusive and representative organisation. His leadership, experience, and dedication to our mission will be invaluable as we continue to drive forward innovation, sustainability, and sector-wide impact.”
Sally Edgington, AXREM CEO said ““I’m absolutely delighted to welcome Bob Childe as AXREM’s new Vice Chair. Bob has been both personally and professionally supportive of me throughout the last six years, and I’ve seen first-hand his unwavering commitment to our sector, our members, and our shared values. His appointment is a testament to how far AXREM has come, now representing over 100 member companies and embracing leadership from across the full spectrum of our community, including SMEs. I’m looking forward to working closely with Bob to continue growing AXREM and enhancing the services we deliver for our members, ensuring we remain a trusted, inclusive, and impactful voice for imaging and oncology technology in the UK.”
AXREM remains committed to shaping a safe, sustainable future for imaging and oncology technology, and Bob’s appointment signals a bold step forward in that journey.
Note:
AXREM members supply the majority of diagnostic medical imaging and radiotherapy equipment installed in UK hospitals. In doing so, our member companies and their employees work side by side with Radiologists, Radiographers, Practitioners, Oncologists and a wide range of healthcare professionals in delivering healthcare to patients using our technologies.
Our members therefore have unique knowledge, experience and insight into the workflow and challenges faced by healthcare professionals on a day-to-day basis, which enables us to develop and offer innovative solutions to improve the speed and quality of diagnostic procedures and treatments with our ultimate aim of improving patient care.
Although our members operate in a highly competitive commercial environment and in strict conformity with UK laws and regulations, certain issues such as this require focus and resolution on an industry-wide basis.
For further information about this press release please contact AXREM Chief Executive Officer – Sally Edgington
AXREM, Rotherwick House, 3 Thomas More Street, London, E1W 1YZ
E sally.edgington@axrem.org.uk
T 07717 058649
